Alverix, Inc., a frontrunner in designing and manufacturing cutting-edge instrument and connectivity platforms, is revolutionizing diagnostic Point-of-Care (POC) testing. The company offers mobile and economical solutions that deliver laboratory-quality performance to diverse locations such as physician office labs, retail clinics, emerging markets, and homes.
Established in 2007 following its spin-off from Hewlett Packard Co., Agilent Technologies, and Avago Technologies, Alverix benefits from a strong 30-year legacy. Headquartered in the heart of Silicon Valley, CA, with a facility in Penang, Malaysia, Alverix provides robust R&D, Quality Control, and customer support, ensuring seamless and optimized transition from concept to large-scale production.
Active in the Biotechnology, Finance, Health Care, and Manufacturing industries, Alverix secured a $7.70M Series A investment in February 2008 from New Venture Partners and Safeguard Scientifics, underlining its strong market potential and appeal as an attractive investment opportunity.